Beta Bionics, Inc. — Form 4/A
Filed September 18, 2026 · analyzed by the Insider Agent
4/A
▼ Likely negative
significance 49/100
What the filing says
Chief Commercial Officer Hopman Mark (BBNX) sold 36K shares (~$665K) on the open market (29% of holdings). Large sale — ~29% of holdings.
Why this rating
Large sale — ~29% of holdings.
See more from September 18, 2026.
EDGAR·FLOW summarizes public SEC EDGAR filings with automated analysis. Materiality scores and stock-impact predictions are algorithmically generated and are not investment advice. Always verify against the source filing on SEC.gov.